These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19553817)

  • 21. How accurate are doctors, nurses and medical students at predicting life expectancy?
    Clarke MG; Ewings P; Hanna T; Dunn L; Girling T; Widdison AL
    Eur J Intern Med; 2009 Oct; 20(6):640-4. PubMed ID: 19782929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate cancer in the elderly.
    Heinzer H; Steuber T
    Urol Oncol; 2009; 27(6):668-72. PubMed ID: 19879477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Techniques and predictive models to improve prostate cancer detection.
    Herman MP; Dorsey P; John M; Patel N; Leung R; Tewari A
    Cancer; 2009 Jul; 115(13 Suppl):3085-99. PubMed ID: 19544550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting outcomes in prostate cancer: how many more nomograms do we need?
    Ross RW; Kantoff PW
    J Clin Oncol; 2007 Aug; 25(24):3563-4. PubMed ID: 17704399
    [No Abstract]   [Full Text] [Related]  

  • 25. Comorbidity assessment in localized prostate cancer: a review of currently available techniques.
    Singh R; O'Brien TS
    Eur Urol; 2004 Jul; 46(1):28-41; discussion 41. PubMed ID: 15183545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Cancer Survival Query System: making survival estimates from the Surveillance, Epidemiology, and End Results program more timely and relevant for recently diagnosed patients.
    Feuer EJ; Lee M; Mariotto AB; Cronin KA; Scoppa S; Penson DF; Hachey M; Cynkin L; Carter GA; Campbell D; Percy-Laurry A; Zou Z; Schrag D; Hankey BF
    Cancer; 2012 Nov; 118(22):5652-62. PubMed ID: 22569947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Nomogram as predictive model in clinical practice].
    Ohori Tatsuo Gondo And Riu Hamada M; Gondo T; Hamada R
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):901-6. PubMed ID: 19542708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomolecular markers of outcome prediction in prostate cancer.
    Lopergolo A; Zaffaroni N
    Cancer; 2009 Jul; 115(13 Suppl):3058-67. PubMed ID: 19544547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can nomograms be superior to other prediction tools?
    Shariat SF; Capitanio U; Jeldres C; Karakiewicz PI
    BJU Int; 2009 Feb; 103(4):492-5; discussion 495-7. PubMed ID: 18990135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
    Jeldres C; Isbarn H; Capitanio U; Zini L; Bhojani N; Shariat SF; Cloutier V; Lattouf JB; Duclos A; Jolivet-Tremblay M; Valiquette L; Saad F; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Aug; 182(2):626-32. PubMed ID: 19535100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Localized prostatic cancer. Survival and loss of life expectancy].
    Brasso K; Friis S; Juel K; Jørgensen T; Iversen P
    Ugeskr Laeger; 1998 Jul; 160(31):4517-20. PubMed ID: 9700306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nomograms for bladder cancer.
    Shariat SF; Margulis V; Lotan Y; Montorsi F; Karakiewicz PI
    Eur Urol; 2008 Jul; 54(1):41-53. PubMed ID: 18207314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of localized prostate cancer in men over 65 years.
    Cooperberg MR; Konety BR
    Curr Opin Urol; 2009 May; 19(3):309-14. PubMed ID: 19357512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive modeling in prostate cancer. Conclusions and reflections.
    Denis LJ; Gospodarowicz MK
    Cancer; 2009 Jul; 115(13 Suppl):3160-2. PubMed ID: 19544535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family physicians could help in predicting life expectancy without prostate cancer.
    Mohan R
    J Clin Oncol; 2008 Feb; 26(4):690-1; author reply 691-3. PubMed ID: 18235137
    [No Abstract]   [Full Text] [Related]  

  • 36. Outcomes and follow-up strategies for patients on active surveillance.
    Dall'Era MA; Carroll PR
    Curr Opin Urol; 2009 May; 19(3):258-62. PubMed ID: 19295434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.
    Krahn MD; Bremner KE; Asaria J; Alibhai SM; Nam R; Tomlinson G; Jewett MA; Warde P; Naglie G
    Urology; 2002 Aug; 60(2):258-63. PubMed ID: 12137823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Individual survival time prediction using statistical models.
    Henderson R; Keiding N
    J Med Ethics; 2005 Dec; 31(12):703-6. PubMed ID: 16319233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting survival in patients with advanced disease.
    Glare P; Sinclair C; Downing M; Stone P; Maltoni M; Vigano A
    Eur J Cancer; 2008 May; 44(8):1146-56. PubMed ID: 18394880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration.
    Sohlberg EM; Thomas IC; Yang J; Kapphahn K; Daskivich TJ; Skolarus TA; Shelton JB; Makarov DV; Bergman J; Bang CK; Goldstein MK; Wagner TH; Brooks JD; Desai M; Leppert JT
    Urol Oncol; 2020 Sep; 38(9):734.e1-734.e10. PubMed ID: 32674954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.